Expression of SIBLINGS, notably BSP and OPN is associated with prostate cancer progression [84,85,86,87]; OPN [86] and BSP [84] can be used as biomarkers of bone metastasis and DSPP has been proposed as a biomarker for prostate cancer diagnosis [88]. This evidence concerns the gene IBSP and prostate carcinoma.